Dermata Therapeutics (DRMA) vs Ernexa Therapeutics (ERNA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Dermata Therapeutics is the larger company by market cap ($2.5 million vs $2.3 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | DRMA | ERNA |
|---|---|---|
| Share price | $0.5095 | $1.36 |
| Market cap | $2.51M | $2.30M |
| 1-day change | -4.23% | -16.56% |
| EPS (TTM) | $-3.28 | $-11.22 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Net income (latest FY) | $-7.56M | $-14.08M |
| 52-week high | $4.66 | $37.50 |
| 52-week low | $0.50 | $1.35 |
| Distance from 52-week high | -89.07% | -96.37% |
| Analyst consensus | none | none |
| Avg. price target upside | +685.08% | +2105.88% |
| Average volume | 2.78M | 43.90K |
| Shares outstanding | 4.93M | 1.69M |
| Employees | 9 | 5 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Dermata Therapeutics
DRMA stock →Dermata Therapeutics, Inc. engages in the development and distribution of over-the-counter pharmaceutical dermatology-focused products in the United States.
Health Care · Biotechnology: Pharmaceutical Preparations · 9 employees
About Ernexa Therapeutics
ERNA stock →Ernexa Therapeutics Inc., a preclinical-stage company, develops induces derived mesenchymal stem cells (iMSC) therapies for the treatment of treatment of cancer and autoimmune disease. The company's lead product is ERNA-101, an allogenic pro-inflammatory cytokine (IL-7/IL-15) secreting iMSC for the treatment of ovarian cancer; and ERNA-201, an anti-inflammatory cytokine (IL-10) secreting iMSC for the treatment of rheumatoid arthritis.
Health Care · Biotechnology: Pharmaceutical Preparations · 5 employees
DRMA vs ERNA FAQ
Which is bigger, Dermata Therapeutics or Ernexa Therapeutics?
Dermata Therapeutics (DRMA) is larger, with a market capitalization of $2.51M compared with $2.30M for Ernexa Therapeutics (ERNA).
Are Dermata Therapeutics and Ernexa Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.